NIS - libdoc.who.int - World Health Organization

Bulbus Allii Sativi
38. Abbruzzese MR, Delaha EC, Garagusi VF. Absence of antimycobacterial
synergism between garlic extract and antituberculosis drugs. Diagnosis and
microbiology of infectious diseases, 1987, 8:79–85.
39. Chaiyasothi T, Rueaksopaa V. Antibacterial activity of some medicinal
plants. Undergraduate special project report, 1975, 75:1–109.
40. Sangmahachai K. Effect of onion and garlic extracts on the growth of certain
bacteria [Thesis]. Thailand, University of Bangkok, 1978:1–88.
41. Farbman et al. Antibacterial activity of garlic and onions: a historical perspective.
Pediatrics infectious disease journal, 1993, 12:613–614.
42. Lawson LD, Hughes BG. Inhibition of whole blood platelet-aggregation by
compounds in garlic clove extracts and commercial garlic products. Thrombosis
research, 1992, 65:141–156.
43. Koch HP, Lawson LD, eds. Garlic, the science and therapeutic application of
Allium sativum l. and related species. Baltimore, Williams and Wilkins, 1996.
44. Kempski HW. Zur kausalen Therapie chronischer Helminthen-Bronchitis.
Medizinische Klinik, 1967, 62:259–260.
45. Soh CT. The effects of natural food-preservative substances on the development
and survival of intestinal helminth eggs and larvae. II. Action on Ancylostoma
duodenale larvae. American journal of tropical medicine and hygiene,
1960, 9:8–10.
46. Araki M et al. Anthelminthics. Yakugaku zasshi, 1952, 72:979–982.
47. Mader FH. Treatment of hyperlipidemia with garlic-powder tablets. Evidence
from the German Association of General Practitioner’s multicentric placebocontrolled,
double-blind study. Arzneimittel-Forschung, 1990, 40:1111–1116.
48. Gebhardt R. Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis
in hepatocytes. Lipids, 1993, 28:613–619.
49. Gebhardt R, Beck H, Wagner KG. Inhibition of cholesterol biosynthesis by
allicin and ajoene in rat hepatocytes and HepG2 cells. Biochimica biophysica
acta, 1994, 1213:57–62.
50. Gebhardt R. Amplification of palmitate-induced inhibition of cholesterol
biosynthesis in cultured rat hepatocytes by garlic-derived organosulfur
compounds. Phytomedicine, 1995, 2:29–34.
51. Yeh YY, Yeh SM. Garlic reduces plasma lipids by inhibiting hepatic cholesterol
and triacylglycerol synthesis. Lipids, 1994, 29:189–193.
52. Petkov V. Pharmacological and clinical studies of garlic. Deutsche Apotheker
Zeitung, 1966, 106:1861–1867.
53. Jain RC. Onion and garlic in experimental cholesterol induced atherosclerosis.
Indian journal of medical research, 1976, 64:1509–1515.
54. Qureshi AA et al. Inhibition of cholesterol and fatty acid biosynthesis in
liver enzymes and chicken hepatocytes by polar fractions of garlic. Lipids,
1983, 18:343–348.
55. Thiersch H. The effect of garlic on experimental cholesterol arteriosclerosis of
rabbits. Zeitschrift für die gesamte experimentelle Medizin, 1936, 99:473–477.
23